FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
08/01/2024
Voltar para busca
Dado oficial do USPTO
GLYCANOSTICS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
GLYCANOSTICS
ST13
US500000079340032Classe
5, 10, 35, 40, 41, 42, 44
Pedido
79340032
Registro
7159631
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
37
Atualização mais recente
08/01/2024
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 10, 35, 40, 41, 42, 44
Data de depósito
22/12/2021
Data de registro
12/09/2023
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
12/09/2023
Última transação
12/09/2023
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
SK
Examinador
BLAKESLEE, RICHARD A
Unidade examinadora
N50
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Glycanostics, s. r. o.
Representantes
Rhett V. Barney Lee & Hayes, PC
Classificação técnica
Classes Nice
Classe 5Classe 10Classe 35Classe 40Classe 41Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
chemical preparations for pharmaceutical purposesfor calibration of diagnostics tests in a form of a glycoprotein standard; diagnostic preparations for medical purposes; chemical preparations for medical purposesfor diagnosis of oncological diseasesautoimmune diseases and neurological diseases; stem cells for medical purposes; biological tissue cultures for medical purposes; diagnostic biomarker reagents for medical purposes; medical test sets comprised of enzymes for medical purposesantibodies for medical purposeslectins being glycan-recognising proteins for medical useglycoprotein standard for medical useenzymatic substrates for medical purposesblocking agents for medical useall for the diagnosis of diseases
Classe 10
Blood testing apparatus; testing apparatus for medical purposes for testing glycans in the nature of complex carbohydrates and sugars attached to proteins and lipids; diagnostic apparatus for medical purposes for testing glycans in the nature of complex carbohydrates and sugars attached to proteins and lipids
Classe 35
Retail store services for pharmaceutical preparationschemical preparations for pharmaceutical purposesdiagnostic preparations for medical purposeschemical preparations for medical purposesstem cells for medical purposesbiological tissue cultures for medical purposesdiagnostic biomarker reagents for medical purposesblood testing apparatustesting apparatus for medical purposesdiagnostic apparatus for medical purposesmedical test sets comprised of enzymes for medical purposesantibodies for medical purposeslectins being glycan-recognising proteins for medical useglycoprotein standard for medical useenzymatic substrates for medical purposesblocking agents for medical useall for the diagnosis of diseases; online retail store services for pharmaceutical preparationschemical preparations for pharmaceutical purposesdiagnostic preparations for medical purposeschemical preparations for medical purposesstem cells for medical purposesbiological tissue cultures for medical purposesdiagnostic biomarker reagents for medical purposesblood testing apparatustesting apparatus for medical purposesdiagnostic apparatus for medical purposesmedical test sets comprised of enzymes for medical purposesantibodies for medical purposeslectins being glycan-recognising proteins for medical useglycoprotein standard for medical useenzymatic substrates for medical purposesblocking agents for medical useall for the diagnosis of diseases
Classe 40
Custom manufacture of medical test sets comprised of enzymes for medical purposesantibodies for medical purposeslectins being glycan-recognising proteins for medical useglycoprotein standard for medical useenzymatic substrates for medical purposesblocking agents for medical useall for the diagnosis of diseases
Classe 41
Educational services in the nature of academiesconducting seminarsworkshopslecturespractical experimental demonstrations in the field of glycomicsbiomarker discoverydisease diagnosticsproteomicslife science company development; arranging and conducting of colloquiums in the field of glycomicsbiomarker discoverydisease diagnosticsproteomicslife science company development; arranging and conducting of conferences in the field of glycomicsbiomarker discoverydisease diagnosticsproteomics; arranging and conducting of congresses in the field of glycomicsbiomarker discoverydisease diagnosticsproteomics; arranging and conducting of seminars in the field of glycomicsbiomarker discoverydisease diagnosticsproteomics; arranging and conducting of symposiums in the field of glycomicsbiomarker discoverydisease diagnosticsproteomics; arranging and conducting of in-person educational forums in the field of glycomicsbiomarker discoverydisease diagnosticsproteomics
Classe 42
Chemical analysis; chemical research; biological research; scientific laboratory services; scientific research; medical and scientific researchconducting clinical validations trials for diagnostic and pharmaceutical companies; medical research
Classe 44
Medical services; pharmacy advicepharmaceutical advice for diagnostic and pharmaceutical companies; health counselling; medical analysis services for diagnostic and treatment purposes provided by medical laboratories
Publicações
Histórico de despachos e eventos da marca no USPTO.
37 publicações encontradas
FICS
FINAL DISPOSITION NOTICE SENT TO IB
14/12/2023
FIMP
FINAL DISPOSITION PROCESSED
14/12/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
12/12/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/09/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
12/09/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
27/06/2023
PUBO
PUBLISHED FOR OPPOSITION
27/06/2023
GPNX
NOTIFICATION PROCESSED BY IB
26/06/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
08/06/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
07/06/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/06/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
23/05/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
24/04/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
24/04/2023
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
24/04/2023
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
12/03/2023
GNFR
FINAL REFUSAL E-MAILED
12/03/2023
CNFR
FINAL REFUSAL WRITTEN
12/03/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
27/02/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
26/02/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
26/02/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
13/01/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
13/01/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
13/01/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
13/01/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
13/01/2023
RFNP
REFUSAL PROCESSED BY IB
04/01/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
10/12/2022
RFRR
REFUSAL PROCESSED BY MPU
09/12/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
29/09/2022
CNRT
NON-FINAL ACTION WRITTEN
28/09/2022
DOCK
ASSIGNED TO EXAMINER
27/09/2022
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
01/07/2022
MAFR
APPLICATION FILING RECEIPT MAILED
17/05/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
13/05/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
12/05/2022
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace GLYCANOSTICS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.